OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases
Sureshbabu Ram Kumar Pandian, Kevin Kumar Vijayakumar, Sankaranarayanan Murugesan, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09575-e09575
Open Access | Times Cited: 23
Sureshbabu Ram Kumar Pandian, Kevin Kumar Vijayakumar, Sankaranarayanan Murugesan, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09575-e09575
Open Access | Times Cited: 23
Showing 23 citing articles:
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Mian Huang, Bingtao Zhai, Yu Fan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4275-4311
Open Access | Times Cited: 33
Mian Huang, Bingtao Zhai, Yu Fan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4275-4311
Open Access | Times Cited: 33
Nanotherapeutics for Meningitis: Enhancing Drug Delivery Across the Blood-Brain Barrier
Hitaishi Sharma, Kannan Badri Narayanan, Shampa Ghosh, et al.
Biomimetics (2025) Vol. 10, Iss. 1, pp. 25-25
Open Access
Hitaishi Sharma, Kannan Badri Narayanan, Shampa Ghosh, et al.
Biomimetics (2025) Vol. 10, Iss. 1, pp. 25-25
Open Access
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
Shuhan Liu, Haisong Li, Shiwen Xi, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1443-1490
Open Access
Shuhan Liu, Haisong Li, Shiwen Xi, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1443-1490
Open Access
Recent Advances in Nanotherapeutics for Neurological Disorders
Arti Vashist, Pandiaraj Manickam, Andrea Raymond, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 7, pp. 2614-2621
Open Access | Times Cited: 18
Arti Vashist, Pandiaraj Manickam, Andrea Raymond, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 7, pp. 2614-2621
Open Access | Times Cited: 18
RGD-decorated nanoparticles: Therapeutic potential beyond cancer
Seyedeh Maryam Hosseinikhah, Fatemeh Vahdat‐Lasemi, Leila Farhoudi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105924-105924
Closed Access | Times Cited: 3
Seyedeh Maryam Hosseinikhah, Fatemeh Vahdat‐Lasemi, Leila Farhoudi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105924-105924
Closed Access | Times Cited: 3
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 3
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 3
Recent developments in selective therapeutic targeting of functionalized nanomaterials to neurovascular units in overcoming the gaps in neurovascular therapy
Sakshi Goswami, Н. К. Исаев, Vladimir V. Salmin, et al.
Brain Disorders (2024) Vol. 15, pp. 100162-100162
Open Access | Times Cited: 3
Sakshi Goswami, Н. К. Исаев, Vladimir V. Salmin, et al.
Brain Disorders (2024) Vol. 15, pp. 100162-100162
Open Access | Times Cited: 3
Astrocytic MicroRNAs and Transcription Factors in Alzheimer’s Disease and Therapeutic Interventions
Ajmal Nassar, Triveni Kodi, Sairaj Satarker, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4111-4111
Open Access | Times Cited: 19
Ajmal Nassar, Triveni Kodi, Sairaj Satarker, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4111-4111
Open Access | Times Cited: 19
ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation
Pooja Khairnar, Ajit Singh, Kailash Ahirwar, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 8
Pooja Khairnar, Ajit Singh, Kailash Ahirwar, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 8
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer's disease
Ashwini Gawade, Satish Polshettiwar, Hetal Hingalajia, et al.
Elsevier eBooks (2024), pp. 391-402
Closed Access | Times Cited: 1
Ashwini Gawade, Satish Polshettiwar, Hetal Hingalajia, et al.
Elsevier eBooks (2024), pp. 391-402
Closed Access | Times Cited: 1
Long-Circulating and Brain-Targeted Liposomes Loaded with Isoliquiritigenin: Formation, Characterization, Pharmacokinetics, and Distribution
Weitong Song, Lu Bai, Pingxiang Xu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 975-975
Open Access | Times Cited: 1
Weitong Song, Lu Bai, Pingxiang Xu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 975-975
Open Access | Times Cited: 1
Brain-on-a-chip: an emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders
Raquel O. Rodrigues, Su-Ryon Shin, Manuel Bañobre‐López
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Raquel O. Rodrigues, Su-Ryon Shin, Manuel Bañobre‐López
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus
Devika Unnithan, Ali Sartaj, Mohammad Kashif Iqubal, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 437-456
Closed Access
Devika Unnithan, Ali Sartaj, Mohammad Kashif Iqubal, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 437-456
Closed Access
Revolutionizing Therapy: Nanomaterials in Liposomes Redefine the Future of Medicinal Drugs
Jerusa Maria de Oliveira, Rener M.F. Duarte, Samaysa de Lima Lins, et al.
IntechOpen eBooks (2024)
Open Access
Jerusa Maria de Oliveira, Rener M.F. Duarte, Samaysa de Lima Lins, et al.
IntechOpen eBooks (2024)
Open Access
Nanomaterials as Drug Delivery Vehicles for Therapy of Parkinson's Disease
Aleena James Chirayimmel, Gursharan Kaur, Palak Rana, et al.
(2024), pp. 303-343
Closed Access
Aleena James Chirayimmel, Gursharan Kaur, Palak Rana, et al.
(2024), pp. 303-343
Closed Access
Nanomaterials and Neurological Disorders Management
Sibasankar Sahu, Debasis Gantayat, Sipu Kumar Sahu, et al.
(2024), pp. 81-107
Closed Access
Sibasankar Sahu, Debasis Gantayat, Sipu Kumar Sahu, et al.
(2024), pp. 81-107
Closed Access
Liposomes against Alzheimer’s Disease: Current Research and Future Prospects
Christiana Constantinou, Katerina Meliou, Αθανάσιος Σκούρας, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1519-1519
Open Access
Christiana Constantinou, Katerina Meliou, Αθανάσιος Σκούρας, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1519-1519
Open Access
Bibliometric analysis of global research trends in magnetic resonance imaging studies of substantia nigra in Parkinson’s disease (2001–2024)
Mei Jiang, Xu Deng, Zixiong Qiu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Mei Jiang, Xu Deng, Zixiong Qiu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Emerging need of novel drug delivery systems in management of CNS disorders
Triveni Tiwari, Aditi Sinha, Manisha Pandey, et al.
Elsevier eBooks (2024), pp. 93-103
Closed Access
Triveni Tiwari, Aditi Sinha, Manisha Pandey, et al.
Elsevier eBooks (2024), pp. 93-103
Closed Access
Neuro-Nanocarriers: Redefining Treatment Pathways for Brain Disorders
Advaita Chauhan, Dhaval Mori, Moinuddin Soniwala, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
Advaita Chauhan, Dhaval Mori, Moinuddin Soniwala, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
Evaluation of Nanomaterials as Effective Carriers Targeted to Traverse Blood–Brain Barrier for Theragnostics of Neurodegenerative Diseases: An Overview
D. Vengadesan, Natarajan Arumugam, E. Manikandan, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
D. Vengadesan, Natarajan Arumugam, E. Manikandan, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
Future Barriers and Possible Solutions with Recent Advances in Alzheimer’s Disease
Ashish Ranjan Dwivedi, Pathuri Raghuveer
(2024), pp. 413-430
Closed Access
Ashish Ranjan Dwivedi, Pathuri Raghuveer
(2024), pp. 413-430
Closed Access
Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment
Andrea Vaquero-Rodríguez, Jone Razquin, Maider Zubelzu, et al.
International review of neurobiology (2023), pp. 103-143
Closed Access | Times Cited: 1
Andrea Vaquero-Rodríguez, Jone Razquin, Maider Zubelzu, et al.
International review of neurobiology (2023), pp. 103-143
Closed Access | Times Cited: 1
Pegylated Nanoparticles for Brain Targeting- Opportunities and Challenges
Utsav Gupta, Shaheen Sultana
Current Nanomedicine (2023) Vol. 13, Iss. 3, pp. 199-209
Closed Access | Times Cited: 1
Utsav Gupta, Shaheen Sultana
Current Nanomedicine (2023) Vol. 13, Iss. 3, pp. 199-209
Closed Access | Times Cited: 1
